Sadhvi Mythili Sarangula

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
After 1 year of introduction of olanzapine long-acting injectable (LAI) in India, many psychiatrists believe that it is a very affordable, well-tolerated, and effective second generation long-acting antipsychotic depot compared to not well tolerated but cheap first generation antipsychotic depots and to other second generation depots which are costly.(More)
  • 1